RetroSense Doses First Patient In Test Of Blindness Drug
ANN ARBOR — The pharmaceutical startup RetroSense Therapeutics LLC Monday announced the first patient in a Phase I/IIa clinical trial of its lead drug candidate, RST-001. The drug is designed …